Telix Pharmaceuticals Ltd. (TLX)
9.43
+0.21
(+2.28%)
USD |
NASDAQ |
Jun 09, 16:00
9.43
0.00 (0.00%)
After-Hours: 19:43
Telix Pharmaceuticals Market Cap : 3.151B for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 64.66B |
| Propanc Biopharma, Inc. | 1.242M |
| Mesoblast Ltd. | 1.229B |
| Amplia Therapeutics Ltd. | 2.003M |
| Agenus, Inc. | 120.00M |
Market Cap Related Metrics
| PS Ratio | 3.961 |
| Price to Book Value | 26.66 |
| Price | 9.43 |
| Earnings Yield | -0.22% |
| Operating PE Ratio | 180.46 |